Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
20-Apr-16 India's Cipla has renewed its focus on over-the-counter (OTC) products five years after it exited the segment. The company aims to build three-to-five INR1 bn (USD5 mn) brands in five years with the launch of novel products and tapping into the growing health and wellness consciousness amongst the urban population. [image: Business Standard]Read More
20-Apr-16 Although the family doctor model has been implemented in many district and communal medical centres in Ho Chi Minh City, it is still an unpopular service among patients. Since people are unaware of the benefits of family doctor clinics, popularising the model remains a challenge. [image: DTiNews]Read More
20-Apr-16 India's healthcare sector is poised to grow to USD280 bn by 2020, is expected to be a leader in e-health by 2019. It should reach USD160 bn by 2017, accounting for 4.2% of GDP. Indian telemedicine is showing robust growth at approximately 20% and is projected to grow from USD8 mn in 2012 to USD19 mn by 2017. [image: Money Control]Read More
20-Apr-16 Singapore’s medical devices industry is aiming to hit SGD5 bn in manufacturing output. The government is targeting up to 1 mn foreign patients a year, which will contribute SGD2.6 bn (USD1.6 bn), or about 1%, to Singapore’s GDP. Already there are 30 global medical technology companies, including the industry’s leading manufacturers, with operations and R&D in Singapore. [image: Asian Briefing].Read More
19-Apr-16 Walgreens Boots Alliance has bought a 15% stake in Russian pharmacy chain 36,6. In return Walgreens Boots Alliance has sold its Russian distributor Alliance Healthcare Russia to 36,6. The country’s commercial drug market can be very promising for foreign investors. [image: Newseurope]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: